256 related articles for article (PubMed ID: 33362243)
1. Glycosylation generates an efficacious and immunogenic vaccine against H7N9 influenza virus.
Kim JI; Park S; Bae JY; Lee S; Kim J; Kim G; Yoo K; Heo J; Kim YS; Shin JS; Park MS; Park MS
PLoS Biol; 2020 Dec; 18(12):e3001024. PubMed ID: 33362243
[TBL] [Abstract][Full Text] [Related]
2. Effects of HA and NA glycosylation pattern changes on the transmission of avian influenza A(H7N9) virus in guinea pigs.
Park S; Lee I; Kim JI; Bae JY; Yoo K; Kim J; Nam M; Park M; Yun SH; Cho WI; Kim YS; Ko YY; Park MS
Biochem Biophys Res Commun; 2016 Oct; 479(2):192-197. PubMed ID: 27613087
[TBL] [Abstract][Full Text] [Related]
3. A recombinant H7N9 influenza vaccine with the H7 hemagglutinin transmembrane domain replaced by the H3 domain induces increased cross-reactive antibodies and improved interclade protection in mice.
Wang Y; Wu J; Xue C; Wu Z; Lin Y; Wei Y; Wei X; Qin J; Zhang Y; Wen Z; Chen L; Liu GD; Cao Y
Antiviral Res; 2017 Jul; 143():97-105. PubMed ID: 28408133
[TBL] [Abstract][Full Text] [Related]
4. Dual N-linked glycosylation at residues 133 and 158 in the hemagglutinin are essential for the efficacy of H7N9 avian influenza virus like particle vaccine in chickens and mice.
Wang Y; Li Q; Peng P; Zhang Q; Huang Y; Hu J; Hu Z; Liu X
Vet Microbiol; 2024 Jul; 294():110108. PubMed ID: 38729093
[TBL] [Abstract][Full Text] [Related]
5. A Single Amino Acid Substitution at Residue 218 of Hemagglutinin Improves the Growth of Influenza A(H7N9) Candidate Vaccine Viruses.
Li X; Gao Y; Ye Z
J Virol; 2019 Oct; 93(19):. PubMed ID: 31270231
[TBL] [Abstract][Full Text] [Related]
6. Development of influenza H7N9 virus like particle (VLP) vaccine: homologous A/Anhui/1/2013 (H7N9) protection and heterologous A/chicken/Jalisco/CPA1/2012 (H7N3) cross-protection in vaccinated mice challenged with H7N9 virus.
Smith GE; Flyer DC; Raghunandan R; Liu Y; Wei Z; Wu Y; Kpamegan E; Courbron D; Fries LF; Glenn GM
Vaccine; 2013 Sep; 31(40):4305-13. PubMed ID: 23891795
[TBL] [Abstract][Full Text] [Related]
7. A Replication-Defective Influenza Virus Harboring H5 and H7 Hemagglutinins Provides Protection against H5N1 and H7N9 Infection in Mice.
Tian X; Landreth S; Lu Y; Pandey K; Zhou Y
J Virol; 2021 Jan; 95(3):. PubMed ID: 33177192
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the Immune Responses to and Cross-Protective Efficacy of Eurasian H7 Avian Influenza Viruses.
Kwon HI; Kim YI; Park SJ; Song MS; Kim EH; Kim SM; Si YJ; Lee IW; Song BM; Lee YJ; Yun SJ; Kim WJ; Choi YK
J Virol; 2017 Jun; 91(11):. PubMed ID: 28331080
[TBL] [Abstract][Full Text] [Related]
9. Divergent H7 immunogens offer protection from H7N9 virus challenge.
Krammer F; Albrecht RA; Tan GS; Margine I; Hai R; Schmolke M; Runstadler J; Andrews SF; Wilson PC; Cox RJ; Treanor JJ; García-Sastre A; Palese P
J Virol; 2014 Apr; 88(8):3976-85. PubMed ID: 24453375
[TBL] [Abstract][Full Text] [Related]
10. Inactivated H7 Influenza Virus Vaccines Protect Mice despite Inducing Only Low Levels of Neutralizing Antibodies.
Kamal RP; Blanchfield K; Belser JA; Music N; Tzeng WP; Holiday C; Burroughs A; Sun X; Maines TR; Levine MZ; York IA
J Virol; 2017 Oct; 91(20):. PubMed ID: 28768855
[TBL] [Abstract][Full Text] [Related]
11. Immunogenicity and protective efficacy of a Vero cell culture-derived whole-virus H7N9 vaccine in mice and guinea pigs.
Wodal W; Schwendinger MG; Savidis-Dacho H; Crowe BA; Hohenadl C; Fritz R; Brühl P; Portsmouth D; Karner-Pichl A; Balta D; Grillberger L; Kistner O; Barrett PN; Howard MK
PLoS One; 2015; 10(2):e0113963. PubMed ID: 25719901
[TBL] [Abstract][Full Text] [Related]
12. Development of a high-yield live attenuated H7N9 influenza virus vaccine that provides protection against homologous and heterologous H7 wild-type viruses in ferrets.
Chen Z; Baz M; Lu J; Paskel M; Santos C; Subbarao K; Jin H; Matsuoka Y
J Virol; 2014 Jun; 88(12):7016-23. PubMed ID: 24719414
[TBL] [Abstract][Full Text] [Related]
13. Recombinant baculovirus vaccine expressing hemagglutinin of H7N9 avian influenza virus confers full protection against lethal highly pathogenic H7N9 virus infection in chickens.
Hu J; Liang Y; Hu Z; Wang X; Gu M; Li R; Ma C; Liu X; Hu S; Chen S; Peng D; Jiao X; Liu X
Arch Virol; 2019 Mar; 164(3):807-817. PubMed ID: 30671655
[TBL] [Abstract][Full Text] [Related]
14. Plant-derived H7 VLP vaccine elicits protective immune response against H7N9 influenza virus in mice and ferrets.
Pillet S; Racine T; Nfon C; Di Lenardo TZ; Babiuk S; Ward BJ; Kobinger GP; Landry N
Vaccine; 2015 Nov; 33(46):6282-9. PubMed ID: 26432915
[TBL] [Abstract][Full Text] [Related]
15. Neuraminidase-Inhibiting Antibody Titers Correlate with Protection from Heterologous Influenza Virus Strains of the Same Neuraminidase Subtype.
Walz L; Kays SK; Zimmer G; von Messling V
J Virol; 2018 Sep; 92(17):. PubMed ID: 29925654
[TBL] [Abstract][Full Text] [Related]
16. Protective efficacy of an inactivated chimeric H7/H5 avian influenza vaccine against highly pathogenic avian influenza H7N9 and clade 2.3.4.4 H5 viruses.
Peng C; Hou G; Li J; Wang S; Wang Y; Cheng S; Yu X; Jin J; Jiang W
Vet Microbiol; 2018 Sep; 223():21-26. PubMed ID: 30173747
[TBL] [Abstract][Full Text] [Related]
17. 220 mutation in the hemagglutinin of avian influenza A (H7N9) virus alters antigenicity during vaccine strain development.
Liu L; Lu J; Li Z; Zhou J; Guo J; Li X; Liu J; Shu Y; Wang D
Hum Vaccin Immunother; 2018 Mar; 14(3):532-539. PubMed ID: 29300686
[TBL] [Abstract][Full Text] [Related]
18. Optimal designs of an HA-based DNA vaccine against H7 subtype influenza viruses.
Zhang L; Jia N; Li J; Han Y; Cao W; Wang S; Huang Z; Lu S
Hum Vaccin Immunother; 2014; 10(7):1949-58. PubMed ID: 25424804
[TBL] [Abstract][Full Text] [Related]
19. Elicitation of Protective Antibodies against 20 Years of Future H3N2 Cocirculating Influenza Virus Variants in Ferrets Preimmune to Historical H3N2 Influenza Viruses.
Allen JD; Jang H; DiNapoli J; Kleanthous H; Ross TM
J Virol; 2019 Feb; 93(3):. PubMed ID: 30429350
[TBL] [Abstract][Full Text] [Related]
20. Recombinant virus-like particles elicit protective immunity against avian influenza A(H7N9) virus infection in ferrets.
Liu YV; Massare MJ; Pearce MB; Sun X; Belser JA; Maines TR; Creager HM; Glenn GM; Pushko P; Smith GE; Tumpey TM
Vaccine; 2015 Apr; 33(18):2152-8. PubMed ID: 25772674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
